We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SY
376
So-Young International
SY
$191M
| $940K | ﹤0.01% |
510,900
-496,708
| -49% | -$1.19M |
|
|
MDC
377
DELISTED
M.D.C. Holdings, Inc.
MDC
| $938K | ﹤0.01% |
20,060
| – | – |
|
378
Realty Income
O
$60.9B
| $934K | ﹤0.01% |
15,620
-6,957
| -31% | -$425K |
|
379
Acme United Corp
ACU
$200M
| $923K | ﹤0.01% |
36,998
+376
| +1% | +$9.54K |
|
380
Snowflake
SNOW
$93.4B
| $922K | ﹤0.01% |
5,237
-3,678
| -41% | -$598K |
|
381
Vanguard US Multifactor ETF
VFMF
$719M
| $908K | ﹤0.01% |
8,741
| – | – |
|
382
York Water
YORW
$504M
| $905K | ﹤0.01% |
21,933
+3,200
| +17% | +$139K |
|
383
Valley National Bancorp
VLY
$8.03B
| $903K | ﹤0.01% |
116,515
+27,312
| +31% | +$217K |
|
384
Caterpillar
CAT
$411B
| $893K | ﹤0.01% |
3,628
+253
| +7% | +$56.4K |
|
|
DNMR
385
DELISTED
Danimer Scientific, Inc.
DNMR
| $893K | ﹤0.01% |
9,375
| – | – |
|
386
Stanley Black & Decker
SWK
$14.2B
| $885K | ﹤0.01% |
9,443
-1,852
| -16% | -$153K |
|
387
C&F Financial
CFFI
$256M
| $875K | ﹤0.01% |
16,295
| – | – |
|
388
Canadian Pacific Kansas City
CP
$82B
| $865K | ﹤0.01% |
10,704
-4,227
| -28% | -$334K |
|
389
EOG Resources
EOG
$77.9B
| $858K | ﹤0.01% |
7,493
+245
| +3% | +$28K |
|
390
Liberty Global Class C
LBTYK
$3.23B
| $857K | ﹤0.01% |
48,242
-6,081
| -11% | -$113K |
|
391
Arrow Electronics
ARW
$10.9B
| $853K | ﹤0.01% |
5,958
| – | – |
|
|
BRKL
392
DELISTED
Brookline Bancorp
BRKL
| $829K | ﹤0.01% |
94,855
-50,202
| -35% | -$458K |
|
393
Oaktree Specialty Lending
OCSL
$1.03B
| $827K | ﹤0.01% |
42,588
-3,766
| -8% | -$70.8K |
|
|
LOV
394
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $813K | ﹤0.01% |
2,581,300
| – | – |
|
395
Evolv Technologies
EVLV
$944M
| $811K | ﹤0.01% |
135,149
-36,708
| -21% | -$174K |
|
396
APi Group
APG
$17.1B
| $809K | ﹤0.01% |
+44,520
| New | +$689K |
|
397
Vanguard Russell 1000 Growth ETF
VONG
$42.8B
| $801K | ﹤0.01% |
11,317
-697
| -6% | -$45.6K |
|
398
Armstrong World Industries
AWI
$6.87B
| $801K | ﹤0.01% |
10,900
-3,500
| -24% | -$238K |
|
399
Ametek
AME
$55.3B
| $792K | ﹤0.01% |
4,890
-2,200
| -31% | -$321K |
|
400
Goldman Sachs
GS
$315B
| $786K | ﹤0.01% |
2,437
-132
| -5% | -$43.4K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.